Antacids Market Share and Growth by Business Development 2020-2025 | AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, Dr. ReddyÕs Laboratories Ltd., GlaxoSmithKline PLC, Johnson & Johnson

Global Antacids Market This market research provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Research classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.

Market Overview-

The Antacids Market is expected to grow, at a CAGR of approximately 4.3% during the forecast period. Some of the key drug categories existing in the antacid market include Proton pump inhibitor, H2 antagonist and acid neutralizers. Out of the three drug categories, proton pump inhibitors segment is expected to hold the largest share in global revenue over the forecast period.

Avail a Sample Copy before Purchase:

https://www.marketinsightsreports.com/reports/01241063931/global-antacids-market-segmented-by-drug-class-formulation-type-distribution-channel-and-geography-growth-trends-and-forecast-2018-2023/inquiry?source=MW&Mode=21

Market competition by Top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the Top players including-

AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, Dr. ReddyÕs Laboratories Ltd., GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Procter & Gamble, Reckitt Benckiser Group PLC, Sanofi, Sun Pharmaceuticals Ltd, Takeda Pharmaceutical, Valeant Pharmaceuticals Internationa

Market segment by Regions/Countries, this report covers
North America (U.S., Canada, Mexico)
Global (Germany, UK, France, Rest of Global)
Asia Pacific (China, India, Japan, Rest of Asia Pacific)
Latin America (Brazil, Argentina, Rest of Latin America) 
Middle East & Africa

Key Market Trends

Growing Geriatric Population Suffering from GERD Induce a Surge in the Antacids Market

People with ages of 60 years or higher is rising at a rate of approximately 3% every year and 65% of geriatric population have to deal with acid reflux, and this is one of the major factors boosting the antacid market globally. According to World Health Organization 2017, more than USD 10 billion is spent globally every year on antacids. As per World Gastroenterology Organization, the prevalence rate of GERD is growing globally and the prevalence reached approximately 2.5% - 6.6% in South East Asia and almost 13.8% - 25.8% in North America. Along with this other factors such as poor lifestyle choices leading to higher incidences of acidity and side effects of drugs like non-steroidal anti-inflammatory drugs will also contribute to the growth of the antacids market during the forecast period.

Side Effects Related to Antacids and Drug Interactions to Impede the growth of Antacids Market

Antacids often lead to milk alkali syndrome and rebound acidity due to dose dependence. Antacids which consist of aluminum hydroxide may cause constipation, aluminum-intoxication, osteomalacia, and hypophosphatemia. Antacids that contain magnesium have a laxative result which might lead to diarrhea, and in patients suffering from kidney failure, the higher magnesium deposits can create further health complications.
Availability of OTC antacids and their common usage in most of the population using other medications can lead to drug interactions and severe side effects. For instance, antacids when taken with acidic drugs like digoxin, chlorpromazine, etc. lead to the absorption of the drugs, due to which the concentration of the drugs in the blood is very low, which in turn reduces the efficacy of the drugs. Other factors which will affect the market growth include lack of awareness about acidity symptoms and growing number of alternatives in the market for antacids.

Get Exclusive Discount at-

https://www.marketinsightsreports.com/reports/01241063931/global-antacids-market-segmented-by-drug-class-formulation-type-distribution-channel-and-geography-growth-trends-and-forecast-2018-2023/discount?source=MW&Mode=21

Europe to Dominate the Antacids Market

Europe accounted for the largest share in the antacids market in 2017 due to factors such as increasing incidence of gastro esophageal reflux diseases and growing geriatric population. The region being home to some of the key players is also stoking growth of this regional market. Asia Pacific stood as the second-leading market for antacids in 2016. The region is anticipated to clock a high and constant CAGR from 2018 - 2023 to account for the second-leading revenue through this period. China and India are key domestic markets in the region due to improvement of healthcare services.

Market Updates-

 Jun 2018: German chemical and pharmaceutical giant Bayer completed the $63 billion mega-deal acquiring the US based biotech major Monsanto.
 Jan 2017: FDA approved Teva's generic version of AstraZeneca's Nexium. The US Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such approval for the drug.
Sep 2017: Lannett Co. Inc. received Food and Drug Administration approval to market a generic version of delayed-release Nexium in 20- and 40-milligram dosages

Major points covered in this research are:-

─Antacids Market Overview, Segment by Type (Product Category), by Application, by Region (2020-2023), Competition by Manufacturers

─Global Market Size (Value) of Antacids (2020-2023)

─Global Antacids Capacity, Production, Revenue (Value), Supply (Production), Consumption, Export, Import by Region (2020-2023)

─Global Antacids Production, Revenue (Value), Price Trend by Type

─Global Antacids Market Analysis by Application

─Global Antacids Manufacturers Profiles/Analysis

─Antacids Manufacturing Cost Analysis

─Industrial Chain, Sourcing Strategy and Downstream Buyers

─Marketing Strategy Analysis, Distributors/Traders

─Market Effect Factors Analysis

─Global Antacids Market Forecast (2020-2023)

─Competitive Landscape

─Research Findings and Conclusion

Finally, this Antacids report covers the market scenario and its development prospects over the coming years. Report likewise manages the type analysis, contrasting it with the significant application, recent Antacids product development and gives an outline of the potential Global market.

Contact US:

Irfan Tamboli (Sales)

Phone: + 1704 266 3234

Mob: +91-750-707-8687

sales@marketinsightsreports.com

irfan@marketinsightsreports.com

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.